GK

Gulzar Khan

Director Director DIN 06926276
DIN 06926276 First appointment Jul 2014 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Gulzar Khan

Data last updated:

Gulzar Khan was a Director at Maxycon Health Care Private Limited (2014) and Managing Director at Indie Globe Pharmaceuticals Private Limited (from 2014). The companies operate in Healthcare.

DIN 06926276
Primary Designation Director
Industry Healthcare
First Appointment 29 Jul 2014
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Maxycon Health Care Private Limited U85100DL2009PTC191380
Director29 Jul 20142009Strike Off
Managing Director18 Dec 20142014₹17.5 Lakh (FY 2016)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indie Globe Pharmaceuticals Private Limited
Maxycon Health Care Private Limited
Premium access

Shareholding and investment profile for Gulzar Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gulzar Khan

Gulzar Khan was first appointed on 29 Jul 2014 as Director at Maxycon Health Care Private Limited.

Gulzar Khan held 2 earlier board appointments: Maxycon Health Care Private Limited (Director, 29 Jul 2014 to 14 Oct 2014); Indie Globe Pharmaceuticals Private Limited (Managing Director, from 18 Dec 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available